Frequently Asked Questions
The global Prosthetic Joint Infections market is expected to be impacted significantly by COVID-19.
North America accounted for the highest share in the global Prosthetic Joint Infections market in terms of value.
As the number of knee and hip replacement procedures increases, so does the risk of infection, which is expected to drive market growth during the forecast period. The increasing demand for prosthetic joint infection treatment has prompted key companies to increase their R&D efforts in order to develop new creative products for the treatment of prosthetic joint infection. Therapeutic molecule clinical trials for PJI are now underway.
Debridement segment had a major share in 2021 with more than 40% of the market revenue share.
Hospital segment had a major share in 2021 with more than 45% of the market revenue share.